We conclude that CO-dependent TTP activation diminishes PAI-1 levels in SGs, leading to alleviation of age-dependent NAFLD and ETO-induced cellular senescence (Fig. 8). The gene discussed is RUNX1T1; the disease is metabolic dysfunction-associated steatotic liver disease.